Specify a stock or a cryptocurrency in the search bar to get a summary
OBiO Technology (Shanghai) Corp. Ltd. A
688238Obio Technology (Shanghai) Corp., Ltd., a biotechnology company, focuses on the development of gene therapy vectors in China. The company provides gene function and gene therapy research, and other CRO services, such as drug target and drug efficacy research. It also offers CDMO services, such as process development and testing, IND-CMC pharmaceutical research, and clinical sample GMP production for the research and development of genetic drugs. The company was founded in 2013 and is headquartered in Shanghai, China. Address: Building 19, Shanghai, China, 201321
Analytics
WallStreet Target Price
46.26 CNYP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures 688238
Dividend Analytics 688238
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History 688238
Stock Valuation 688238
Financials 688238
Results | 2019 | Dynamics |